D. Carmier
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Occupational and environmental lung diseases
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- P. Diot (6 shared papers)Élisabeth Diot (4 shared papers)Sylvain Marchand-Adam (6 shared papers)Éric Pichon (4 shared papers)Théodora Bejan‐Angoulvant (1 shared paper)Valérie Gounant (4 shared papers)Emmanuelle Vermès (1 shared paper)Marion Campana (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Clinical Infectious Diseases (2 papers)Cancers (2 papers)The Lancet Oncology (1 paper)Journal of Clinical Medicine (1 paper)
- Partner nations
- France
In The Last Decade
D. Carmier
22 papers receiving 846 citations
D. Carmier's Hit Papers
Peers
Comparison fields: 5 of 41
- Oncology 346
- Pulmonary and Respiratory Medicine 402
- Rheumatology 63
- Genetics 15
- Cancer Research 18
Countries citing papers authored by D. Carmier
This map shows the geographic impact of D. Carmier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Carmier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Carmier more than expected).
Fields of papers citing papers by D. Carmier
This network shows the impact of papers produced by D. Carmier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Carmier. The network helps show where D. Carmier may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Carmier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial Hit paper breakdown → | 2019 | 364 |
| 2 | 2019 | 149 | |
| 3 | Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer Hit paper breakdown → | 2024 | 108 |
| 4 | 2010 | 44 | |
| 5 | 2020 | 39 | |
| 6 | 2011 | 32 | |
| 7 | 2018 | 30 | |
| 8 | 2011 | 23 | |
| 9 | 2008 | 20 | |
| 10 | 2013 | 17 | |
| 11 | 2018 | 9 | |
| 12 | 2015 | 8 | |
| 13 | 2022 | 8 | |
| 14 | 2022 | 5 | |
| 15 | 2017 | 2 | |
| 16 | 2017 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2013 | 1 | |
| 20 | 2020 | 1 |
About D. Carmier
D. Carmier is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Rheumatology, Parasitology and Dermatology, having authored 23 papers that have together received 868 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Treatments and Mutations (4 papers), Systemic Lupus Erythematosus Research (3 papers), Lung Cancer Research Studies (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Dermatology and Skin Diseases (1 paper) and Systemic Sclerosis and Related Diseases (1 paper). The work is most often cited by research in Oncology (346 citations), Pulmonary and Respiratory Medicine (402 citations), Rheumatology (63 citations), Genetics (15 citations) and Cancer Research (18 citations). D. Carmier has collaborated with scholars based in France. Frequent co-authors include P. Diot, Élisabeth Diot, Sylvain Marchand-Adam, Éric Pichon, Théodora Bejan‐Angoulvant, Valérie Gounant, Emmanuelle Vermès, Marion Campana, Marion Ferreira and Franck Morin. Their work appears in journals such as Annals of Oncology, Clinical Infectious Diseases, Cancers, The Lancet Oncology and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.